For example, 45%–60% of human gastric cancers do not express RUNX3 due to hemizygous deletion and hypermethylation of the RUNX3 promotor, and Runx3 knock-out mice develop hyperplasia of the gastric mucosa [40]. This evidence concerns the gene RUNX3 and gastric cancer.